Reporting suspected adverse drug reactions: Information for the Pharmaceutical Industry

Please click the links on the left side for information on the following:

• Information on company receipt of Anonymised Single Patient Reports (ASPRs)
• Questions and answers on E2B reporting

Pharmacovigilance Service Desk: Providing a service to marketing authorisation (MA) holders
We recently introduced a new Pharmacovigilance Service Desk .

The aim of the Service Desk is to be the first port-of-call for marketing authorisation (MA) holders and their representatives, enquiring about any pharmacovigilance related matters and any associated regulatory activity. 

We aim to provide an answer to all enquiries within seven working days of receipt.  If we are unable to respond directly we will refer to other relevant areas of the Agency.  In such cases, we may need to revise the response timeframe and will keep you informed. 

The Pharmacovigilance Service Desk will be manned between the hours of 09:00 and 17:00, Monday - Friday and can be contacted by telephone or preferably by e-mail at:pharmacovigilanceservice@mhra.gsi.gov.uk. 

The service desk aims to be a “one-stop shop” for MA holder enquiries relating to Pharmacovigilance.  For submitting suspected adverse drug reaction reports, we ask that you continue to follow previously issued guidelines. Should there be any questions about this new service, please contact Zamshed Harun, Service Desk Coordinator, on 020 7084 2242 or by e-mail at zamshed.harun@mhra.gsi.gov.uk.  Alternatively, the Service Desk Team Leader, Lance Smithson on 020 7084 2764 or by e-mail at lance.smithson@mhra.gsi.gov.uk.